Diana Jackson will be teaching a course during this program entitled ‘Co-ordinated merger effects and non-horizontal mergers.”
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
